Bionime Corp. | Income Statement
Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,561
1,525
1,610
1,740
1,820
2,007
Cost of Goods Sold (COGS) incl. D&A
969
982
958
1,023
1,072
1,142
Gross Income
592
543
651
717
748
866
SG&A Expense
447
393
462
459
499
625
EBIT
145
149
190
-
249
241
Unusual Expense
-
3
15
45
-
58
Non Operating Income/Expense
-
2
5
22
39
7
Interest Expense
23
66
58
22
23
29
Pretax Income
124
86
123
214
189
162
Income Tax
34
32
24
35
40
34
Consolidated Net Income
90
54
99
179
150
128
Net Income
90
54
99
179
150
128
Net Income After Extraordinaries
90
54
99
179
150
128
Net Income Available to Common
90
54
99
179
150
128
EPS (Basic)
2.02
1.22
1.91
2.82
2.60
2.23
Basic Shares Outstanding
45
44
52
63
57
57
EPS (Diluted)
2.01
1.22
1.90
2.80
2.57
2.20
Diluted Shares Outstanding
45
44
52
64
58
58
EBITDA
250
297
343
416
395
392
Non-Operating Interest Income
2
3
2
1
2
2
About Bionime
View Profile
